-
Tranilast (INN,
brand name Rizaben) is an
antiallergic drug. It was
developed by
Kissei Pharmaceuticals and was
approved in 1982 for use in ****an and...
- "Uncontrollable
prurigo nodularis effectively treated by
roxithromycin and
tranilast".
Journal of
Drugs in Dermatology. 5 (4): 363–365. PMID 16673805. Hyde...
-
unresectable plexiform neurofibroma and low-grade astrocytomas. In vitro,
tranilast,
inhibits growth of
neurofibroma cells. Gene
therapy for the neurofibromin...
-
related 4-quinazolinone-based
pharmaceutical drugs, including:
Tioperidone Tranilast Pelanserin Diproqualone Antrafenine SJ-733
Nicafenine Molinazone Cloperidone...
-
Linzagolix Mitiglinide (Glufast)
Remogliflozin etabonate Silodosin (Urief)
Tranilast (Rizaben) In
March 2020,
Kissei and CG Oncology, Inc.
announced an exclusive...
-
Trandate trandolapril (INN)
trandolaprilat (INN)
tranexamic acid (INN)
tranilast (INN)
Tranmep Trans-Ver-Sal
transcainide (INN)
Transderm scop Transderm-Nitro...
-
Medical therapies include topical atropine,
topical retinoids, and oral
tranilast. The most
common adverse effects include redness, skin discoloration,...
- barrier.
Avenanthramides also have a
chemical structure similar to the drug
tranilast,
which has anti-histaminic action. The anti-itch
activity of avenanthramides...
- fibers. Oral retinoids, such as tretinoin, and
antifibrotic agents like
tranilast have been
tested for pseudo-ainhum.
Impending am****tion in Vohwinkel...
- ****atsu H,
Yamamoto M (2002). "Treatment of
oligoasthenozoospermia with
tranilast, a mast cell blocker,
after long-term administration".
Archives of Andrology...